July 23, 2025

FDA Grants Breakthrough Status to Melanoma Test

The FDA has granted Breakthrough Device designation to Castle Biosciences’ DecisionDx-Melanoma test, a gene expression profile assay designed to improve risk stratification and personalized care in cutaneous melanoma.

Conexiant

July 22, 2025

Placenta Accreta Guidelines Lack Consensus: Review

A new review of clinical guidelines highlights consistent recommendations for diagnosing and managing placenta accreta spectrum disorders, but showed gaps in guidance for surgery, fertility counseling, and postnatal care, especially in low-resource settings.

Conexiant

July 22, 2025

Might That Lip Lesion Be BCC?

New research has documented 4 cases of lip basal cell carcinoma presenting as smooth yellow nodules—a rare clinical presentation that may be mistaken for benign mesenchymal tumors, potentially resulting in diagnostic delays and postponed treatment.

Conexiant

July 18, 2025

New Guideline Sets Standards for Sinus Surgery

A new guideline outlines when surgery is appropriate for chronic rhinosinusitis, urging clinicians to confirm diagnosis, assess candidacy, and consider long-term management needs.

Conexiant

July 15, 2025

Fibrinogen Concentrate Reduces Blood Loss in Surgery

In a phase 3 trial, a purified human fibrinogen concentrate reduced intraoperative blood loss and lowered thromboembolic risks compared with fresh frozen plasma or cryoprecipitate during major surgeries.

Conexiant

July 11, 2025

Bariatric Surgeries Reverse Liver Fibrosis

Bariatric surgeries led to greater long-term reductions in liver fat and fibrosis than endoscopic options.

Conexiant

July 11, 2025

Patients With Sludge Pancreatitis Have Fewer Complications

An international cohort study found that patients with sludge- or microlithiasis-induced acute pancreatitis had significantly fewer long-term complications than those with gallstone-related pancreatitis.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 01, 2025

Stem Cell Therapy Shows T1D Reversal Potential

A new stem cell–derived islet therapy showed insulin independence, restored beta-cell function, and prevented severe hypoglycemia in type 1 diabetes, based on interim results presented at the ADA’s 85th Scientific Sessions.

Conexiant